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Summary.-Saline extracts of human bronchogenic tumours, soluble in 50%
saturated ammonium sulphate and also fractions from Sephadex G-200 chromato-
graphy were used to raise antisera in rabbits. After absorbing the antisera with
normal tissue extracts, direct Ouchterlony tests were performed against tumour
(adenocarcinomata and squamous cell carcinomata) and normal extracts. A
precipitin reaction was given with all 11 tumour extracts tested at a concentration
of5 mg/ml whereas all the 9 normal lung control extracts did not react at concentra-
tions up to 100 mg/ml. The possibility that this reaction could be related to histo-
compatibility differences between individuals is ruled out by the fact that in two
cases tumour and normal tissue were obtained from the same patient. These
studies and also precipitin-inhibition experiments have confirmed the existence of
an antigen associated with bronchial carcinomata and have shown that, although
the antigen or a cross-reacting antigen is present in normal lungtissue,the amounts
are small in comparison with the amounts extracted from tumour. Antigenic
activity was contained in a single absorbance peak when fractionated by Sephadex
G-200 chromatography and its elution volume indicated a molecular weight of ap-
proximately4.0 x 104 D. Further purification was achieved using isotachophoresis.
Preliminary characterization of the antigen has shown it to be stable at pH 4*5,
resistant to heating at 50°C for 30 min, to migrate on immunoelectrophoresis with
a cationic mobility at pH8*5 and to be immunologically distinctfrom carcinoembryo-
nic antigen.
IMMUJNOCHEMICAL studies have shown
the existence of several human tumour
associated antigens (AJexander, 1972;
Cinader, 1972; Avis and Lewis, 1973).
Two of the most widely studied are
carcinoembryonic antigen (CEA), origin-
ally thought to be specifically associated
with colon carcinoma (Gold and Freed-
man, 1965) and alpha-foetoprotein (Tata-
rinov, 1964) found in the serum ofpatients
with hepatocellular carcinoma or tera-
toma. Both of these sntigens have been
found in foetal tissues. Other studies
(Yachi et al., 1968) employing absorbed
heterologous antisera have demonstrated
by double diffusion at least 2 tumour
associated antigens in saline extracts
ofbronchial carcinomata. These antigens
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were both soluble in 50% saturated
ammonium sulphate but appeared to
differ in molecular size. The smaller
antigen (7S) in particular was not only
related to lung cancer-an identical or
partially related antigen was found also
in tumours of colon, stomach, pancreas,
kidney and liver. It had an electro-
phoretic mobility in the alpha-beta region
(pH 8.6) and is very similar in character
to a lung tumour antigen recently re-
ported by Sega et al. (1974) although its
identity had not been established. Using
similar techniques McIntire and Sizaret
(1974) have also detected 2 different
antigens associated with carcinoma of the
lung.
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for the existence of a different, more
basic, bronchial tumour antigen soluble
in 50% saturated ammonium sulphate
and report preliminary studies on its
purification and characterization.
MATERIALS AND METHODS
Specimens.-Tumour specimens of lung
and bronchus, and in 2 cases corresponding
normal lung tissue, were obtained surgically.
Autopsy specimens obtained within 24 h
of death were also used. All tissues were
either processed immediately or stored at
-20°C until used.
Extraction of tissue antigens.-Neoplastic
and normal tissue were extracted using a
method similar to that described by Yachi et
al. (1968). The tissues were cut into small
pieces, washed briefly with water to remove
blood, minced and homogenized in an equal
volume of 0.9% saline for approximately
10 min using a Townson and Mercer top
drive macerator. The suspension was then
centrifuged at 30,000 g for 1 h, the super-
natant decanted and the residue resuspended
in saline (250 ml/kg of fresh tissue) and
recentrifuged. The pooled supernatants
were brought to pH 4-5 by adding N HC1
dropwise and the precipitate removed by
centrifugation at 75,000 g for 30 m1i. The
supernatant was concentrated in an Amicon
cell using a PM 10 membrane and then
fractionated by the dropwise addition of an
equal volume of saturated ammonium sul-
phate solution at 4°C. The stirred suspen-
sion was kept at 4°C for 2 h and centrifuged
at 30,000 g for 1 h. The soluble fraction
was then dialysed against running tap water
for 2 days, concentrated to about 200 ml
(Amicon PM 10), dialysed against distilled
water and freeze-dried.
Antisera.-A pooled extract of primary
well differentiated adenocarcinomata (2 speci-
mens) was used to raise an antiserum (G54)
for initial studies. Based on the method
of Yachi et al. (1968), 15 mg of extract for
each rabbit was dissolved in saline (1 ml),
sterilized by filtration through a 0-22 ,um
Millipore membrane and emulsified in an
equal volume ofFreund's complete adjuvant.
Each rabbit received multiple-site intra-
dermal injections in the flank, a similar
booster injection being given approximately
40 days later. Trial bleeds were started
10 days later and the sera absorbed with
pooled normal lung extract (40 mg/ml),
freeze-dried normal human plasma (20 mg/
ml), a saline extract of normal liver and
spleen (20 mg/ml) and an extract of lung
tissue (20 mg/ml) taken more than 7 cm
from the periphery of the tumour used to
raise the antiserum. Similar inoculation
schedules were employed to raise antisera
from antigen containing fractions of extracts
of primary bronchial tumour (MF 1 and
MF 2) and liver metastases from a squamous
cell bronchial tumour (MF 3 and MF 4)
which had previously been chromatographed
on Sephadex G-200. Each antiserum was
absorbed with a pool of normal lung extract
(40 mg/ml) and freeze-dried normal human
plasma (20 mg/ml) by mixing and leaving at
37°C overnight. The antiserum was centri-
fuged at 2750gfor20minandthesupernatant
filtered through a 0-22 um Millipore mem-
brane. Sodium azide was added as a
preservative.
Fractionation of tumour extracts.-Frac-
tionation of extracts of primary and second-
ary bronchial tumours was performed with
a Sephadex G-200 column (5.3 cm x 89 cm).
The column was equilibriated with 0 05
mol/l phosphate buffer at pH 7-2 containing
0-15 mol/l NaCl. Freeze-dried tumour ex-
tract (200 mg) was dissolved in this buffer,
filtered through a 5 ,tm membrane and
applied to the column. A flow rate of
20 ml/h was maintained throughout the
elution procedure. The effluent samples
were monitored by u.v. absorption at 280 nm
and tested by Ouchterlony double diffusion
using appropriate antisera. Fractions show-
ing a reaction with the absorbed antisera
were pooled, dialysed against distilled water
and freeze dried. Isotachophoresis was per-
formed using an LKB Uniphore preparative
apparatus as described in the operating
manual employing 5.5% polyacrylamide gel
in a 50 ml column. The leading and
terminating buffers were 0-067 mol/l Tris/
phosphate pH 6-75 and 0-012 mol/l Tris/0-23
mol/lE-aminocaproic acidpH8-7respectively.
The sample (180 mg of G-200 fractionated,
extract of liver metastases of a bronchial
tumour), applied to the column in the
terminating buffer (15 ml), incorporated
Ampholine spacers (pH 5-10). The #ow
rate was 20 ml/h and the maximum current
applied 15 mA.
Immunological methods. - Immunodiffu-
sion experiments were carried out in 1-5%
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purified Agar (Oxoid) in 0.9% saline on plates
I 0 mm thick. Wrells were 8 mm apart
and filled with 10 dul of antigen solution or
antisera. The tumour extracts in saline
w%Aere generally tested at 5 mg/ml and the
inormal tissue extracts at a range of concen-
trations up to 100 mg/ml. Immunoelectro-
phoresis was carried out in 1-5% Agar gel
in 0 05 mol/l barbitone buffer (pH 8&5) using
plates 1-0 mm thick. Precipitin-inhibition
studies w%Nere carried out using absorbed
antisera which wNere treated with successive
additions of freeze-dried tumour or normal
extracts. The antisera were incubated at
37°C for 2 h and at 4°C overniight after
each addition of extract and the centrifuged
antiserum tested by direct double diffusion
against a primary and secondary bronchial
tumour extract (10 mg/ml). Interaction
betwreen these extracts and the antiserum
absorbed with the standard amounts of
normal extracts was previously shown to
give a reproducible sharp pattern of a
single tumour associated precipitin band.
RESULTS
Initial studies were made with ainti-
serum G54. All antiserum bleeds were
absorbed as described earlier and tested
against various bronchial tumour and
normal lung extracts. Bleeds 1 and 2
produced two precipitin arcs (Fig. 1)
against the tumour exti-acts but not
against normal extracts at concentrations
up to 100 mg/ml. Further absorption of
these antisera (up to 200 mg of protein)
did not inhibit the fornmation of these
arcs. Subsequent bleeds, however, did
not produce precipitin lines after absorp-
tion with normal lung extract and a
further booster failed to restore anti-
tumour activity. Bleeds 1 and 2 from
each rabbit were pooled and used for
monitoring the Sephadex G-200 fractiona-
tion. These initial experiments suggested
that possibly two tissue antigens associ-
ated with bronchial carcinoma are detect-
able and although the normal extracts
failed to react at the concentrations
stated, the possibility of the antigens
being present in normal lung tissues at
low concentrations was not excluded.
SCHEMATIC
Vie. 1 Double diffusion reactioins of an
extract of primary bronchial tumTnotur
(centre well) with variouts antisera: Wells a
andt b G 54;c AlMF4/bleed 7; d AM F3/bleed 2;
and e Ml9.F3/bleed 7.
These antigens are unlikely to be related
to histocompatibility differences between
individuals since extracts of corresponding
normal and tumour tissue were obtained
from the same donors; in addition,
absorbed antisera reacted with tumour
extracts from many different individuals.
Further antisera were raised using
positive fractions obtained from Sephadex
G-200 chromatography. Both antigens
appeared in a single absorbance peak.
Antisera MF 1 and AIF 2 produced very
weak precipitin lines after absorption
and were discarded. Antisera MF 3
and AIF 4, however, produced clear
reactions after absorption although the
lines were partially masked by coloured
impurities in the antiserum. Ouchterlony
double diffusion reactions using unab-
©
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TABLE.-Precipitin-Inhibition Studies by Bronchial Tumour and Normal Lung Extracts
using Pre-absorbed Antisera. Figures show minimum Amount (mg) of Extract Able
to Inhibit 1 ml of Antiserum
Antiserum
Extracts
Bronchial tumour
Primary
Primary
Primary
Liver metastases
Liver metastases
Liver metastases
Liver metastases
Liver metastases
Liver metastases
Normal lung
MF3 (bleed 5) MF4 (bleed 5) Pool 1 Pool 2
2
Single specimen 100
Single specimen 100
Pool of 5 specimens
sorbed antisera showed multiple precipitin
lines when tested against tumour and
normal tissue extracts and tumour dis-
tinctive lines could not be resolved.
After absorption with pooled normal lung
extracts andpoolednormalhumanplasma,
a single precipitin line was obtained with
tumour extracts. This line was shown
to be identical to the line nearest the
antiserum well given by bleeds 1 and 2
of antiserum G 54 (Fig. 1). Antibodies
to the second antigen could not be
detected in this case.
Extracts of the following tissues have
been studied: 4 primary bronchial adeno-
carcinomata, 7 liver metastases from
bronchial tumour (adenocarcinoma and
squamous cell carcinoma) and 9 specimens
devoid of malignant disease. All the
tumour extracts gave the same single
reproducible precipitin line at 5 mg/ml
whereas the normal extracts failed to
react at 75 mg/ml and at 100 mg/ml,
except in the cases where the normal
and tumour were obtained from the same
specimen; in these cases a very weak line
of continuity with the tumour line was
observed at the higher concentration of
normal tissue. This result suggests pos-
sible microscopic tumour infiltration or
disturbance of local cellular metabolism
in the apparently normal tissue (Khoo et
al., 1973).
2 3-4 3-4
3
3
3
3
2-3 2-3
3
3
3
100 110
200
150
Precipitin-inhibition reactions have
been designed to determine the minimum
amounts of various tissue extracts re-
quired to inhibit the formation of the
tumour associated precipitin arcs. The
results, summarized in the Table, have
been shown to be reproducible and
independent of whether the inhibiting
extract was added to the antiserum in
separate serially diluted solutions or as a
freeze-dried solid added successively as
described earlier. The latter method was
used routinely to conserve antisera. Four
antisera were used, MF 3 bleed 5, MF 4
bleed .5 and 2 separate pools consisting of
bleeds 1 and 2 of antiserum G 54 and
various bleeds of antisera MF 3 and
MF 4. In all cases using extracts of
tumours, inhibition was achieved with
low levels of antigen (2-4 mg/ml), de-
pending on the antiserum (Fig. 2a).
Normal extracts inhibited at concentra-
tions greater than 100 mg/ml in excess
of the standard 40 mg/ml used in the
initial absorption. Figure 2b shows that
absorption of the antiserum with 100
mg/ml of normal extract still fails to
inhibit the reaction. These results clearly
indicate a significant difference in the
concentration of antigen in bronchial
tumours and their metastases in liver,
compared with normal lung tissue.
The tumour associated antigen was
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69)
a)
A B
SCHEMATIC
FIG. 2.-Precipitin-inhibition of absorbed antiserum. The middle wells each contain an extract
of primary bronchial tumour at 10 mg/ml. (A) Well a contains antiserum pool 1. Wells b, c, d, e
and f contain the same antiserum absorbed with 1, 2, 3, 4 and 5 mg/ml of an extract of liver
metastases of bronchial tumour respectively. (B) Antiserum pool 1 (well a) was absorbed with
additional normal lung extract. Wells b, c, d, e and f contain the absorbed antiserum further
absorbed with 10, 20, 50, 75 and 100 mg/ml respectively. (The poor contrast of the double
diffusion plates was caused by using highly absorbed antisera which imparted a coloured back-
ground and partially masked the precipitin lines.)
found to be soluble in 50% saturated
ammonium sulphate solution and saline
at neutral and acid pH. The elution
pattern of an extract ofprimary bronchial
tumour from a Sephadex G-200 column
showed 3 major peaks (Fig. 3) and im-
munodiffusion tests showed the antigenic
activity to be associated with the second
peak. Using a calibrated column, this
peak was eluted at approximately 300 ml,
indicating a molecular size of4 0 x 104 D.
An approximately three-fold purification
of the antigen was obtained, based on
the weight of the active fraction after
dialysis and freeze-drying.
Further purification of the antigen
was achieved using preparative isotacho-
phoresis. Inpreliminary studies, Ampho-
line spacers from pH 5-10 were incor-
porated in the sample. The elution
pattern shows 5 major peaks (Fig. 4).
The eluate was collected in 5 ml fractions
and every fifth fraction tested by double
diffusion against an absorbed antiserum.
Antigenic activity was associated with
peak IV eluted at 300 ml, indicating the
antigen to be essentially basic in character.
An approximately 20-fold purification of
the antigen was obtained at this stage
based on the weight of active material
afterdialysis and freeze-drying and assum-
ing that losses of antigen were minimal.
The ultraviolet spectrum of fraction IV
(A max, 278 nm, A min 252 nm) indicates
that nucleic acid is probably absent from
this fraction.
The antigen could not be recovered
from perchloric acid extracts of both
primary and secondary bronchial tumours.
It was shown by double diffusion experi-
ments to be immunologically distinct
from CEA and our antisera MF 3 and
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-200 chromatography of an extract (200 mg) of liver metastases
of a bronchial tumour.
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FIG. 4.-Isotachophoresis of an extract (I 80 mg) of liver metastases of a bronchial tumouri- previously
fractionated on Sephaclex G-200. Insert show%Ns immunoelectrophoresis of the bronchial tumour
antigen at pH 8-5.
MF 4 also failed to react with purified complete inhibition of the precipitin
CEA at concentrations of 0 5 and 1-0 reaction was observed. The basic charac-
mg/ml. In order to test its stability to ter of the antigen was confirmed by its
heat, extracts of primary and secondary cationic mobility in immunoelectropho-
bronchial tumours known to contain the resis at pH 85.
antigen were maintained at 50°C and
75°C for 30 min and at 100NC for 10 min.
Incubation at 50°C had no effect on the
formation of the precipitin reaction but
after treatment at the higher temperatures
DISCUSSION
The results of this study show the
existence of a tumour associated antigen
in bronchial adenocarcinoma and squa-
0.3
9.1
0.8
0.4
0.2
0.1
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mous cell carcinoma. It is also shown
from the precipitin-inhibition studies that
an apparently similar antigen is present
in small amounts in normal lung tissue
obtained at autopsy. In this respect
the antigen is similar to the " Y " antigen
isolated from lung tumours by Yachi et
al. (1968). The latter antigen was also
shown to be cross-reactive with a foetal
antigen and appeared in extracts of
tumours from other organs. CEA and
alpha-foetoprotein are also present in
normal and foetal tissues and there is
evidence that such oncofoetal antigens
may be associated not only with malignant
disease but also with pathological condi-
tions in which cell regeneration is pre-
valent.
One major difficulty whenusing hetero-
logous antisera prepared by inoculating
animals with semi-purified extracts of
tumours is adequate absorption of the
antisera with respect to anti-normal
components (Witebskey, Rose and Shul-
man, 1956; Gold, 1971). This has been
emphasized by Yachi et al. (1968), who
examined various absorption methods.
Gold and Freedman (1965) used absorbed
heterologous anti-CEA antisera and com-
pared their results with an unabsorbed
antiserum raised byinjecting colontumour
extract in rabbits which were made
tolerant to normal colon components
during neonatal life. Although true im-
munological tolerance is difficult to
achieve, both methods produced specific
anti-CEA antisera. Another method
which may have wide application in the
future involves the use of immunoadsor-
bent columns for isolating antibodies
specific for human lung carcinoma anti-
gens (Watson, Smith and Levy, 1974).
In the present preliminary study, antisera
were absorbed with normal lung, liver
and spleen tissue extracts at concentra-
tions up to 200 mg/ml although in coni-
trast to the findings of Yachi et al. (1968)
60 mg of protein/ml of antiserum was
adequate for complete absorption of anti-
normal antibodies. Although the anti-
sera were coloured, we had no difficulty
in observing precipitin arcs even after
the antisera had been stored for several
months at -20°C.
Autolysis and bacterial contamination
of surgically removed tissue and autopsy
specimens are difficult to avoid com-
pletely and could lead to proteolytic
degradation of tissues, rendering them
incapable of effective absorption of anti-
normal antibodies and in the case of
tumour tissue to the isolation of artefacts.
Using saline extracts and antisera
MF3 and MF4, we have consistently
found the tumour antigen in all bronchial
tumours studied by double diffusion.
It can be distinguished from the antigens
described by Yachi et al. (1968) and
Sega et al. (1974) by its significantly
smaller molecular size and its cationic
mobility. It is similar, however, in its
solubility in ammonium sulphate solution
and its stability to acid and heat. An
increase in the concentration of basic
proteins in phosphate-saline extracts of
bronchogenic tumours has previously been
observed by Louis, Blunck and Richmond
(1973) using agarose gel electrophoresis.
No attempt, however, was made to
isolate and further characterize these
components.
The occurrence of our antigen in foetal
tissue and its cross-reactivity with antigens
extracted from tumours of different origin
and histological types are presently being
studied.
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